ATE175978T1 - Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität - Google Patents

Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität

Info

Publication number
ATE175978T1
ATE175978T1 AT93919457T AT93919457T ATE175978T1 AT E175978 T1 ATE175978 T1 AT E175978T1 AT 93919457 T AT93919457 T AT 93919457T AT 93919457 T AT93919457 T AT 93919457T AT E175978 T1 ATE175978 T1 AT E175978T1
Authority
AT
Austria
Prior art keywords
activity
igf
specific molecules
increase igf
antibodies
Prior art date
Application number
AT93919457T
Other languages
English (en)
Inventor
Jennifer Margaret Pell
Peter Charles Bates
Claire Elisabeth Hamil Stewart
Original Assignee
Biotech & Biolog Scien Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech & Biolog Scien Res filed Critical Biotech & Biolog Scien Res
Application granted granted Critical
Publication of ATE175978T1 publication Critical patent/ATE175978T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93919457T 1992-08-20 1993-08-20 Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität ATE175978T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929217696A GB9217696D0 (en) 1992-08-20 1992-08-20 Use of specific binding molecules

Publications (1)

Publication Number Publication Date
ATE175978T1 true ATE175978T1 (de) 1999-02-15

Family

ID=10720662

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93919457T ATE175978T1 (de) 1992-08-20 1993-08-20 Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität

Country Status (8)

Country Link
EP (1) EP0656908B1 (de)
AT (1) ATE175978T1 (de)
AU (1) AU674697B2 (de)
CA (1) CA2141861A1 (de)
DE (1) DE69323204D1 (de)
GB (1) GB9217696D0 (de)
NZ (1) NZ255461A (de)
WO (1) WO1994004569A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501472D0 (sv) * 1995-04-21 1995-04-21 Pharmacia Ab Truncated IGF-I
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
JP2002535967A (ja) 1999-01-06 2002-10-29 ジェネンテック・インコーポレーテッド インシュリン様成長因子（ｉｇｆ）ｉ変異体
AU762351B2 (en) 1999-01-06 2003-06-26 Genentech Inc. Insulin-like growth factor (IGF) I mutant variants
US6040292A (en) * 1999-06-04 2000-03-21 Celtrix Pharmaceuticals, Inc. Methods for treating diabetes
DE60120372T2 (de) 2000-03-24 2007-07-05 Genentech Inc., San Francisco Verwendung von insulin zur behandlung von knorpelkrankheiten
ATE389416T1 (de) 2000-05-16 2008-04-15 Genentech Inc Behandlung von knorpelerkrankungen
CN100439397C (zh) 2001-02-09 2008-12-03 基因技术股份有限公司 Igf-1的结晶
WO2002072780A2 (en) 2001-03-14 2002-09-19 Genentech, Inc. Igf antagonist peptides
AU2002368305A1 (en) * 2002-10-31 2004-05-25 Universita'degli Studi Di Roma "La Sapienza" Antimicrobial lipase antibodies their nucleotide and aminoacid sequences and uses thereof
EP2274978B1 (de) 2003-09-12 2015-05-20 Tercica, Inc. Verfahren zur Behandlung von IGF-1 (insulin-like growth factor 1)-Mangel
ATE492562T1 (de) 2003-09-24 2011-01-15 Kyowa Hakko Kirin Co Ltd Rekombinanter antikörper gegen humanen insulin- like growth factor
EP1802333A2 (de) 2004-09-13 2007-07-04 Arrowsmith Technologies LLP In-vivo-antikörperpufferung eines liganden
JP2009525319A (ja) 2006-02-02 2009-07-09 ライナット ニューロサイエンス コーポレイション ｔｒｋＢアンタゴニストを投与することにより肥満を治療する方法
EP1989226A4 (de) * 2006-03-06 2009-11-18 Caregen Co Ltd Peptide mit insulin like growth factor-1-aktivitäten und anwendungen davon
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy
KR101669140B1 (ko) 2015-04-28 2016-10-26 (주)케어젠 항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도
US20210008172A1 (en) 2019-07-11 2021-01-14 Opko Biologics Ltd. Long-acting igf-1 or igf-1 variants and methods of producing same

Also Published As

Publication number Publication date
NZ255461A (en) 1996-12-20
AU674697B2 (en) 1997-01-09
CA2141861A1 (en) 1994-03-03
EP0656908A1 (de) 1995-06-14
GB9217696D0 (en) 1992-09-30
AU4967393A (en) 1994-03-15
WO1994004569A1 (en) 1994-03-03
DE69323204D1 (de) 1999-03-04
EP0656908B1 (de) 1999-01-20

Similar Documents

Publication Publication Date Title
DE69323204D1 (de) Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität
ATE207520T1 (de) Durch aldehyd geharteterklebstoff auf basis von protein
DE68916537D1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
DE69423911D1 (de) Neue retinoidkonjugate zur behandlung von alterserscheinungen der haut
ATE250426T1 (de) Verwendung von verbindungen die an ein zytoplasmatischen dipeptidase binden zur potenzierung des immunantworts
ATE77937T1 (de) Kosmetisches praeparat.
ATE238802T1 (de) Zusammensetzung von glibenclamid und metformine zur behandlung von diabetes mellitis typ ii
DE69316948D1 (de) Lösliche Liganden für CD40
DE69407758D1 (de) Antikörper zur behandlung von insulinabhängigen diabetes
DE69033735D1 (de) Varianten von adhäsionsmoleküle für blutplättchen
PT92278A (pt) Processo para a preparacao de proteinas de ligacao de factor de crescimento semelhante a insulina
NO904023D0 (no) Blanding som induserer binding.
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
ATE410514T1 (de) Calciumbindende rekombinante antikörper gegen protein c
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
IL99580A0 (en) Antagonists of human gamma interferon
DE69622259D1 (de) Cd40 bindendes protein zur stimulierung der immunantwort
CA2008817A1 (en) M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
ATE205188T1 (de) Carboxylierte aminoguanidine zur behandlung von insulin-unabhängigem diabetes mellitus
Heatwole The concept of the econe, a fundamental ecological unit.
RU95107066A (ru) Композиционный гуминокремнеземный сорбент
DE69429224D1 (de) Zwischenprodukte für die Synthese von Cephalosporinen
ATE180679T1 (de) Neue verbesserungen hinsichtlich der radiomarkierung von proteinen
DK0404750T3 (da) Vævsinhibitor for metalloproteaser
ATE179969T1 (de) Verfahren zur isomerisierung von olefinen